MyHorryNews

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with BRCA2-mut ...

Immune 'switch' identified as a potential target to curb chronic inflammation in cirrhosis

Chronic liver inflammation is one of the most serious complications associated with liver cirrhosis. Researchers from Miguel ...
Gastroenterology Advisor

Diabetes Subgroups Possess Specific Comorbidity Risk Profiles

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in …

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca ...
gut.bmj

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease

19 Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore 24 Center for Digestive Diseases Research and Clinical Translation of Shanghai Jiao Tong University, Shanghai, ...